A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine

Biological Psychiatry

Volumn 43, Issue 7, 1998, Pages 511-519

  Jelovac, Nikola ^a   Sikirić, Predrag ^a   Ručman, Rudolf ^a   Petek, Marijan ^a   Perović, Darko ^a   Konjevoda, Paško ^a   Marović, Anton ^a   Seiwerth, Sven ^a   Grabarević, Željko ^a   Sumajstorčić, Jagoda ^a   Dodig, Goran ^a   Perić, Josip ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Amphetamine stereotypy; Dopamine system; Haloperidol induced amphetamine supersensitivity; Pentadecapeptide BPC 157

Indexed keywords

AMPHETAMINE; GLYCYLGLUTAMYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; HALOPERIDOL; PENTAPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AUDITORY STIMULATION; DRUG EFFECT; DRUG SENSITIVITY; MALE; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; STARTLE REFLEX; STEREOTYPY;

AMINO ACID SEQUENCE; AMPHETAMINE; ANIMALS; ANTI-ULCER AGENTS; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; HALOPERIDOL; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEINS; RATS; RATS, WISTAR; STARTLE REACTION; STEREOTYPED BEHAVIOR;

EID: 0032054863     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00277-1     Document Type: Article

References (45)

1. Adams JD, Odunze IN (1991): Biochemical mechanisms of l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Biochem Pharmacol 41:1099-1105.
2. Angrist B, van Kammen DP (1984): CNS stimulants as tools in the study of schizophrenia. Trends Neurosci 7:388-390.
3. Bosnjak ZJ, Graf BM, Sikiric P, Stowe DF (1994): Protective effects of newly isolated gastric peptide following hypoxic and reoxygenation injury in the isolated guinea pig heart. FASEB J 8:A
4. Bourne HR, Sanders DA, McCormick F (1990): The GTP-ase superfamily: A conserved switch for diverse cell functions. Nature 348:125-132.
5. Brauer LH, de Wit H (1996): Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biol Psychiatry 39:26-32
6. Connell PH (1958): Amphetamine Psychosis. London: Chapman Hall.
7. Costall B, Naylor RJ (1972): Possible involvement of a noradrenergic area of the amygdala with stereotyped behaviour. Life Sci 11:1135-2246.
8. Costentin J, Protais P, Schwartz JC (1975): Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain. Nature 257:405-407.
9. Dawson-Saunders B, Trapp RG (1994): Basic & Clinical Biostatistics. East Norwalk, CT: Appleton & Lange.
10. Ernst AM (1967): Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia (Berl) 10:316-323.
11. Esterle TM, Sanders-Bush E (1991): From neurotransmitter to gene: Identifying the missing links, TIPS 12:357-379.
12. Fonnum F, Storm-Mathisen J, Divac I (1981): Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibres in rat brain. Neuroscience 6:863-873.
13. Groves PM, Rebec GV (1976): Biochemistry and behavior: Some central action of amphetamine and antipsychotic drugs. Annu Rev Psychol 27:91-127.
14. Guglietta A (1992): Possible clinical use of peptide growth factors in the GI tract: Perspectives and obstacles. Exp Clin Gastroenterol 3:1-6.
15. Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC (1984): Protection against the dopaminergic neurotoxicity of 1-methyl-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311:467-469.
16. Hernandez DE (1986): Neuroendocrine mechanisms of stress ulceration: Focus on thyrotropin releasing hormone (TRH). Life Sci 39:279-296.
17. Kemp JM (1970): The site of termination of fibres from the cerebral cortex and thalamus upon dendritic spines in the caudate nucleus: A study with the Golgi method. Philos Trans R Soc Lond (Biol) 262:429-439.
18. Kiraly I, Borsy J, Tapfer M, Toldy L, Toth I (1980): Neuroleptic activity of new ester derivatives of phenotiazines. In: Usdin E, Eckert H, Forrest IS, editors. Phenotiazines and Structurally Related Drugs: Basic and Clinical Studies. New York, Elsevier/North-Holland, pp 57-60.
19. Krieger TD (1983): Brain peptides: What, where, and why? Science 222:975-985.
20. Lannes B, Micheletti G, Warter JM, Kempf E, Di Scala G (1991): Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat. Neurosci Lett 128:177-181.
21. 2 dopamine receptor-mediated mechanisms and behavioral supersensitivity. Pharmacol Biochem Behav 45:195-200.
22. Masuda Y, Murai S, Saito H, Abe H, Fujiwara H, Kohori I, et al (1991): The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice. Neuropharmacology 30:35-40.
23. Moore KE (1967): Amphetamine: Biochemical and behavioral actions in animals. In: Iverson L, Iverson D, Snyder SH, editors. Handbook of psychopharmacology: Volume II. Stimulants. New York: Plenum Press, pp 41-98.
24. Paré W, Kluczynski JM (1992): The effect of new gastric juice peptide BPC on classic stress triad in stress procedure. Exp Clin Gastroenterol 2:234-236.
25. Parkes D (1974): Amantadine. Adv Drug Res 8:11-81.
26. Protais P, Costentin J, Schwartz JC (1976): Climbing behavior induced by apomorphine in mice: A simple test for the study of dopamine receptors in the striatum. Psychopharmacology 50:1-6.
27. Randrup A, Munkvard I (1966): Role of catecholammes in the amphetamine excitatory response. Nature 211:540.
28. Randrup A, Munkvard I (1967): Stereotyped activities reproduced by amphetamine in several animals species and man. Psychopharmacologia (Berl) 11:300-310.
29. Sandor Z, Vincze A, Szabo S (1996): The protective effect of a recently isolated gastric peptide in acute and chronic gastroduodenal injury. FASEB J 10:171.
30. Sikirić P, Gyires K, Seiwerth S, Grabarevic Z, Rucman R, Petek M, et al (1993a): The effect of pentadecapeptide BPC 157 on inflammatory, non-inflammatory, direct and indirect pain and capsaicin neurotoxicity. Inflammopharmacology 2:1057-1063.
31. Sikirić P, Petek M, Rucman R, Seiwerth S, Grabarevic Z, Rotkvic I, et al (1993b): A new gastric juice peptide BPC - An overview of stomach/stress/organoprotection hypothesis and BPC beneficial effects. J Physiol Paris 87:313-327.
32. Sikirić P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Rotkvic I, et al (1993c): Hepatoprotective effect of BPC 157, a 15-aminoacid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation of CC14 application. A comparative study with dopamine agonists and somatostatin. Life Sci 53:PL291-PL296.
33. Sikirić P, Seiwerth S, Grabarevic Z, Petek M, Rucman R, Turkovic B, et al (1994): The beneficial effect of BPC 157, a 15 aminoacid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promoters and gut peptides. Life Sci 54:PL63-PL68.
34. Sikirić P, Rotkvic I, Mise S, Seiwerth S, Grabarevic Z, Petek M, et al (1995): Dopamine agents efficacy in peptic ulcer healing and relapse prevention - A further indication for importance of stomach dopamine in the stress organoprotection concept. In: Szabo S, Taché Y, Glavin G, editors. Neuroendocrinology of Gastrointestinal Ulceration: Hans Selye Symposia on Neuroendocrinology and Stress, vol 2. New York: Plenum, pp 221-230.
35. Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, et al (1996a): Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats. Dig Dis Sci 41:1518-1526.
36. Sikirić P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, et al (1996b): The beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin and capsaicin neurotoxicity. Dig Dis Sci 41:1604-1614.
37. Sikirić P, Mazul B, Seiwerth S, Grabarevic Z, Rucman R, Petek M, et al (1997a): Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress. Dig Dis Sci. 42:661-671.
38. Sikirić P, Mikus D, Seiwerth S, Grabarevic Z, Rucman R, Petek M, et al (1997b): Pentadecapeptide BPC 157, cirnetidine. ranitidine, bromocriptine and atropine effect in cysteamine lesions in totally gastrectomized rats: A model study for cytoprotective studies. Dig Dis Sci. 42:1029-1037
39. G-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure. Eur J Pharmacol 332:23-33.
40. Thompson J, Greeley GH Jr, Rayford PL, Twonsed CM Jr (1987): Gastrointestinal Endocrinology. New York: McGraw-Hill.
41. Veljaca M, Lesch CA, Pllana R, Sanchez B, Chan K, Guglietta A (1994a): BPC-15 reduces trinitrobenzene sulfonic acid-induced colonie damage in rats. J Pharmacol Exp Ther 272:417-422.
42. Veljaca M, Pllana R, Lesch CA, Sanchez B, Chan K, Guglietta A (1994b): Protective effect of BPC 157 on a rat model of colitis. Gastroenterology 106:789.
43. Veljaca M, Chan K, Guglietta A (1995a): Digestion of h-EGF, h-TGF alpha, and BPC-15 in human gastric juice. Gastroenterology 108:761.
44. Veljaca M, Lesch CA, Sanchez B, Low J, Guglietta A (1995b): Protection of BPC-15 on TNBS-induced colitis in rats: Possible mechanisms of action. Gastroenterology 108:936.
45. Wolkin A, Sanfillipo M, Angrist B, Duncan E, Wieland S, Wolf AP, et al (1994): Acute d-amphetamine challenge in schizo-phrenia: Effects on cerebral glucose utilization and clinical symptomatology. Biol Psychiatry 36:317-325.